JP2024546107A5 - - Google Patents
Info
- Publication number
- JP2024546107A5 JP2024546107A5 JP2024534260A JP2024534260A JP2024546107A5 JP 2024546107 A5 JP2024546107 A5 JP 2024546107A5 JP 2024534260 A JP2024534260 A JP 2024534260A JP 2024534260 A JP2024534260 A JP 2024534260A JP 2024546107 A5 JP2024546107 A5 JP 2024546107A5
- Authority
- JP
- Japan
- Prior art keywords
- group
- optionally substituted
- alkyl
- cyano
- occurrence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163287866P | 2021-12-09 | 2021-12-09 | |
| US63/287,866 | 2021-12-09 | ||
| US202263393440P | 2022-07-29 | 2022-07-29 | |
| US63/393,440 | 2022-07-29 | ||
| PCT/US2022/081236 WO2023108103A1 (en) | 2021-12-09 | 2022-12-09 | Raf kinase inhibitors and methods of use thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024546107A JP2024546107A (ja) | 2024-12-17 |
| JP2024546107A5 true JP2024546107A5 (enExample) | 2025-12-16 |
Family
ID=85018968
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024534260A Pending JP2024546107A (ja) | 2021-12-09 | 2022-12-09 | Ｒａｆキナーゼ阻害剤及びその使用方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20230357179A1 (enExample) |
| EP (1) | EP4444430A1 (enExample) |
| JP (1) | JP2024546107A (enExample) |
| CN (1) | CN119585242A (enExample) |
| AU (1) | AU2022405115A1 (enExample) |
| CA (1) | CA3240192A1 (enExample) |
| TW (1) | TW202342442A (enExample) |
| WO (1) | WO2023108103A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3746059B1 (en) | 2018-01-31 | 2026-03-04 | Deciphera Pharmaceuticals, LLC | Combination therapy for the treatment of gastrointestinal stromal tumors |
| CN121419963A (zh) * | 2023-06-13 | 2026-01-27 | 德西费拉制药有限责任公司 | 双重raf及微管蛋白抑制剂及其使用方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1505064A1 (en) * | 2003-08-05 | 2005-02-09 | Bayer HealthCare AG | 2-Aminopyrimidine derivatives |
| US7737155B2 (en) | 2005-05-17 | 2010-06-15 | Schering Corporation | Nitrogen-containing heterocyclic compounds and methods of use thereof |
| US8906944B2 (en) * | 2009-09-03 | 2014-12-09 | Allergan, Inc. | Compounds as tyrosine kinase modulators |
| AR090151A1 (es) | 2012-03-07 | 2014-10-22 | Lilly Co Eli | Compuestos inhibidores de raf |
| WO2016038582A1 (en) * | 2014-09-12 | 2016-03-17 | Novartis Ag | Compounds and compositions as raf kinase inhibitors |
| CN113874381A (zh) * | 2019-03-22 | 2021-12-31 | 金耐特生物制药公司 | Raf激酶的抑制剂 |
| BR112022007612A2 (pt) * | 2019-10-24 | 2022-09-20 | Kinnate Biopharma Inc | Inibidores de raf quinases |
| US11407737B2 (en) * | 2020-09-18 | 2022-08-09 | Kinnate Biopharma Inc. | Inhibitors of RAF kinases |
-
2022
- 2022-12-09 US US18/078,269 patent/US20230357179A1/en active Pending
- 2022-12-09 JP JP2024534260A patent/JP2024546107A/ja active Pending
- 2022-12-09 WO PCT/US2022/081236 patent/WO2023108103A1/en not_active Ceased
- 2022-12-09 CN CN202280091224.0A patent/CN119585242A/zh active Pending
- 2022-12-09 EP EP22847085.2A patent/EP4444430A1/en active Pending
- 2022-12-09 AU AU2022405115A patent/AU2022405115A1/en active Pending
- 2022-12-09 CA CA3240192A patent/CA3240192A1/en active Pending
- 2022-12-09 TW TW111147359A patent/TW202342442A/zh unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN115734966A (zh) | 杂环化合物及其用途 | |
| DK2197878T3 (en) | FORMATIONS OF kinase inhibitors AND USE THEREOF FOR THE TREATMENT OF CANCER AND OTHER DISEASES RELATED TO kinases | |
| JP2008528467A5 (enExample) | ||
| JP2015517574A5 (enExample) | ||
| JP2007534695A5 (enExample) | ||
| JP2024546478A5 (enExample) | ||
| JP2010265302A5 (enExample) | ||
| CN114430739A (zh) | Egfr抑制剂、组合物及其制备方法 | |
| WO2004112793B1 (en) | Guanidino-substituted quinazolinone compounds as mc4-r agonists | |
| JP2021519786A5 (enExample) | ||
| RU2010106878A (ru) | Комбинация антимитотического агента и ингибитора аврора киназы как средство для лечения рака | |
| JP2021512059A5 (enExample) | ||
| JP2015526519A5 (enExample) | ||
| RU2005136368A (ru) | Производные пиперазина и их применение для лечения неврологических и психиатрических заболеваний | |
| JP2022548250A5 (enExample) | ||
| JP2010501003A5 (enExample) | ||
| JP2011511095A5 (enExample) | ||
| RU2014115847A (ru) | Пирролопиримидиновые соединения для лечения злокачественной опухоли | |
| EP1122242A1 (en) | Cyanophenyl derivatives | |
| KR20130129244A (ko) | 치환된 6,6-융합된 질소 헤테로환형 화합물 및 이의 용도 | |
| JP2023533203A5 (enExample) | ||
| JP2013522292A5 (enExample) | ||
| CN111315744B (zh) | 杂芳基并四氢吡啶类化合物、其制备方法、药物组合物及应用 | |
| JP2010520893A5 (enExample) | ||
| JP2023531709A5 (enExample) |